Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

MAIA Biotechnology, Inc. (MAIA) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

MAIA Biotechnology, Inc. (MAIA), most recent 12 months reported: net loss $26.85M. Latest balance sheet on file: liquid cash $27.6M. From SEC filings. Others in Pharmaceutical Preparations: LB PHARMACEUTICALS INC · Lite Strategy, Inc. · LARIMAR THERAPEUTICS, INC. · LANTERN PHARMA INC. · Veradermics, Inc · MUSTANG BIO, INC. · Moleculin Biotech, Inc. · MBX Biosciences, Inc.

Stock screener

Watchlist